PPD
$34.899876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$34.89
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.49 (+1.42%) As of 1:46 PM EDT today
Why Robinhood?
You can buy or sell PPD and other stocks, options, ETFs, and crypto commission-free!
About PPD
PPD, Inc. provides drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. The firm also provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations and other industry participants. Read More Its clinical development services include all phases of development (Phase I-IV), peri- and post-approval and site and patient access services; laboratory services offers advanced testing services, including bioanalytical, biomarker, vaccine, good manufacturing practice and central laboratory services. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. The listed name for PPD is PPD, Inc. Common Stock.
Employees
23,000
Headquarters
Wilmington, North Carolina
Founded
1985
Market Cap
12.17B
Price-Earnings Ratio
215.04
Dividend Yield
—
Average Volume
4.55M
High Today
$35.02
Low Today
$34.34
Open Price
$34.81
Volume
1.02M
52 Week High
$35.70
52 Week Low
$10.61
Analyst Ratings
94%
of 16 ratings
Buy
94%
Hold
6%
Sell
0%
PPD Earnings
$0.00
$0.11
$0.22
$0.33
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 3, After Hours